SG11201811159SA - Methods for multi-resolution analysis of cell-free nucleic acids - Google Patents
Methods for multi-resolution analysis of cell-free nucleic acidsInfo
- Publication number
- SG11201811159SA SG11201811159SA SG11201811159SA SG11201811159SA SG11201811159SA SG 11201811159S A SG11201811159S A SG 11201811159SA SG 11201811159S A SG11201811159S A SG 11201811159SA SG 11201811159S A SG11201811159S A SG 11201811159SA SG 11201811159S A SG11201811159S A SG 11201811159SA
- Authority
- SG
- Singapore
- Prior art keywords
- international
- cell
- genomic regions
- pct
- regions
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6806—Preparing nucleic acids for analysis, e.g. for polymerase chain reaction [PCR] assay
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B30/00—ICT specially adapted for sequence analysis involving nucleotides or amino acids
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q1/00—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
- C12Q1/68—Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving nucleic acids
- C12Q1/6813—Hybridisation assays
- C12Q1/6827—Hybridisation assays for detection of mutation or polymorphism
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B20/00—ICT specially adapted for functional genomics or proteomics, e.g. genotype-phenotype associations
- G16B20/20—Allele or variant detection, e.g. single nucleotide polymorphism [SNP] detection
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B25/00—ICT specially adapted for hybridisation; ICT specially adapted for gene or protein expression
- G16B25/10—Gene or protein expression profiling; Expression-ratio estimation or normalisation
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B40/00—ICT specially adapted for biostatistics; ICT specially adapted for bioinformatics-related machine learning or data mining, e.g. knowledge discovery or pattern finding
- G16B40/30—Unsupervised data analysis
-
- G—PHYSICS
- G16—INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR SPECIFIC APPLICATION FIELDS
- G16B—BIOINFORMATICS, i.e. INFORMATION AND COMMUNICATION TECHNOLOGY [ICT] SPECIALLY ADAPTED FOR GENETIC OR PROTEIN-RELATED DATA PROCESSING IN COMPUTATIONAL MOLECULAR BIOLOGY
- G16B5/00—ICT specially adapted for modelling or simulations in systems biology, e.g. gene-regulatory networks, protein interaction networks or metabolic networks
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2535/00—Reactions characterised by the assay type for determining the identity of a nucleotide base or a sequence of oligonucleotides
- C12Q2535/122—Massive parallel sequencing
-
- C—CHEMISTRY; METALLURGY
- C12—BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
- C12Q—MEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
- C12Q2537/00—Reactions characterised by the reaction format or use of a specific feature
- C12Q2537/10—Reactions characterised by the reaction format or use of a specific feature the purpose or use of
- C12Q2537/159—Reduction of complexity, e.g. amplification of subsets, removing duplicated genomic regions
Landscapes
- Life Sciences & Earth Sciences (AREA)
- Health & Medical Sciences (AREA)
- Chemical & Material Sciences (AREA)
- Engineering & Computer Science (AREA)
- Physics & Mathematics (AREA)
- Bioinformatics & Cheminformatics (AREA)
- Organic Chemistry (AREA)
- Biotechnology (AREA)
- Biophysics (AREA)
- General Health & Medical Sciences (AREA)
- Proteomics, Peptides & Aminoacids (AREA)
- Analytical Chemistry (AREA)
- Genetics & Genomics (AREA)
- Molecular Biology (AREA)
- Zoology (AREA)
- Wood Science & Technology (AREA)
- Medical Informatics (AREA)
- Bioinformatics & Computational Biology (AREA)
- Evolutionary Biology (AREA)
- Spectroscopy & Molecular Physics (AREA)
- Theoretical Computer Science (AREA)
- General Engineering & Computer Science (AREA)
- Microbiology (AREA)
- Immunology (AREA)
- Biochemistry (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Data Mining & Analysis (AREA)
- Computer Vision & Pattern Recognition (AREA)
- Artificial Intelligence (AREA)
- Bioethics (AREA)
- Physiology (AREA)
- Databases & Information Systems (AREA)
- Epidemiology (AREA)
- Evolutionary Computation (AREA)
- Public Health (AREA)
- Software Systems (AREA)
- Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
- Investigating Or Analysing Biological Materials (AREA)
- Apparatus Associated With Microorganisms And Enzymes (AREA)
Applications Claiming Priority (4)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US201662402940P | 2016-09-30 | 2016-09-30 | |
US201762468201P | 2017-03-07 | 2017-03-07 | |
US201762489391P | 2017-04-24 | 2017-04-24 | |
PCT/US2017/054607 WO2018064629A1 (en) | 2016-09-30 | 2017-09-29 | Methods for multi-resolution analysis of cell-free nucleic acids |
Publications (1)
Publication Number | Publication Date |
---|---|
SG11201811159SA true SG11201811159SA (en) | 2019-01-30 |
Family
ID=61760169
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
SG11201811159SA SG11201811159SA (en) | 2016-09-30 | 2017-09-29 | Methods for multi-resolution analysis of cell-free nucleic acids |
Country Status (10)
Country | Link |
---|---|
US (7) | US20200013482A1 (ja) |
EP (2) | EP3792922A1 (ja) |
JP (5) | JP6560465B1 (ja) |
KR (2) | KR20210158870A (ja) |
CN (1) | CN109642250A (ja) |
AU (2) | AU2017336153B2 (ja) |
CA (2) | CA3027919C (ja) |
ES (1) | ES2840003T3 (ja) |
SG (1) | SG11201811159SA (ja) |
WO (1) | WO2018064629A1 (ja) |
Families Citing this family (13)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PL2697397T3 (pl) | 2011-04-15 | 2017-08-31 | The Johns Hopkins University | System bezpiecznego sekwencjonowania |
US11525163B2 (en) | 2012-10-29 | 2022-12-13 | The Johns Hopkins University | Papanicolaou test for ovarian and endometrial cancers |
WO2017027653A1 (en) | 2015-08-11 | 2017-02-16 | The Johns Hopkins University | Assaying ovarian cyst fluid |
CN115044645A (zh) | 2015-11-11 | 2022-09-13 | 分析生物科学有限公司 | Dna文库的高效率构建 |
WO2017181146A1 (en) | 2016-04-14 | 2017-10-19 | Guardant Health, Inc. | Methods for early detection of cancer |
US20190287645A1 (en) * | 2016-07-06 | 2019-09-19 | Guardant Health, Inc. | Methods for fragmentome profiling of cell-free nucleic acids |
RU2019108294A (ru) | 2016-08-25 | 2020-09-25 | Резолюшн Байосайенс, Инк. | Способы обнаружения изменений количества геномных копий в образцах днк |
ES2840003T3 (es) | 2016-09-30 | 2021-07-06 | Guardant Health Inc | Métodos para análisis multi-resolución de ácidos nucleicos libres de células |
JP7232476B2 (ja) | 2017-08-07 | 2023-03-08 | ザ ジョンズ ホプキンス ユニバーシティ | がんを評価及び治療するための方法及び物質 |
US20210155992A1 (en) * | 2018-04-16 | 2021-05-27 | Memorial Sloan Kettering Cancer Center | SYSTEMS AND METHODS FOR DETECTING CANCER VIA cfDNA SCREENING |
WO2023282916A1 (en) | 2021-07-09 | 2023-01-12 | Guardant Health, Inc. | Methods of detecting genomic rearrangements using cell free nucleic acids |
EP4205126A1 (en) | 2020-08-25 | 2023-07-05 | Guardant Health, Inc. | Methods and systems for predicting an origin of a variant |
CN117935921A (zh) * | 2024-03-21 | 2024-04-26 | 北京贝瑞和康生物技术有限公司 | 确定缺失/重复类型的方法、设备、介质和程序产品 |
Family Cites Families (98)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
CH686982A5 (fr) | 1993-12-16 | 1996-08-15 | Maurice Stroun | Méthode pour le diagnostic de cancers. |
US5648245A (en) | 1995-05-09 | 1997-07-15 | Carnegie Institution Of Washington | Method for constructing an oligonucleotide concatamer library by rolling circle replication |
CA2248981C (en) | 1996-03-15 | 2009-11-24 | The Penn State Research Foundation | Detection of extracellular tumor-associated nucleic acid in blood plasma or serum using nucleic acid amplification assays |
US6329179B1 (en) | 1996-03-26 | 2001-12-11 | Oncomedx, Inc. | Method enabling use of extracellular RNA extracted from plasma or serum to detect, monitor or evaluate cancer |
US6232066B1 (en) * | 1997-12-19 | 2001-05-15 | Neogen, Inc. | High throughput assay system |
EP1165839A2 (en) | 1999-03-26 | 2002-01-02 | Whitehead Institute For Biomedical Research | Universal arrays |
AU767983B2 (en) | 1999-04-09 | 2003-11-27 | Esoterix Genetic Laboratories, Llc | Methods for detecting nucleic acids indicative of cancer |
DE60045059D1 (de) | 1999-04-20 | 2010-11-18 | Nat Inst Of Advanced Ind Scien | Verfahren und Sonden zur Bestimmung der Konzentration von Nukleinsäure-Molekülen und Verfahren zur Analyse der gewonnenen Daten |
US6440706B1 (en) | 1999-08-02 | 2002-08-27 | Johns Hopkins University | Digital amplification |
US6849403B1 (en) | 1999-09-08 | 2005-02-01 | Exact Sciences Corporation | Apparatus and method for drug screening |
US6586177B1 (en) | 1999-09-08 | 2003-07-01 | Exact Sciences Corporation | Methods for disease detection |
US7368233B2 (en) | 1999-12-07 | 2008-05-06 | Exact Sciences Corporation | Methods of screening for lung neoplasm based on stool samples containing a nucleic acid marker indicative of a neoplasm |
US20020072058A1 (en) | 2000-03-24 | 2002-06-13 | Voelker Leroy L. | Method for amplifying quinolone-resistance-determining-regions and identifying polymorphic variants thereof |
EP1158055A1 (fr) | 2000-05-26 | 2001-11-28 | Xu Qi University of Teaxs Laboratoire de Leucémie Chen | Méthode pour le diagnostic de cancers |
CA2426824A1 (en) | 2000-10-24 | 2002-07-25 | The Board Of Trustees Of The Leland Stanford Junior University | Direct multiplex characterization of genomic dna |
EP1342794B1 (en) | 2002-03-05 | 2005-12-14 | Epigenomics AG | Method and device for determination of tissue specificity of free floating DNA in bodily fluids |
US7727720B2 (en) | 2002-05-08 | 2010-06-01 | Ravgen, Inc. | Methods for detection of genetic disorders |
US7635564B2 (en) * | 2002-10-25 | 2009-12-22 | Agilent Technologies, Inc. | Biopolymeric arrays having replicate elements |
US10229244B2 (en) | 2002-11-11 | 2019-03-12 | Affymetrix, Inc. | Methods for identifying DNA copy number changes using hidden markov model based estimations |
WO2005010145A2 (en) | 2003-07-05 | 2005-02-03 | The Johns Hopkins University | Method and compositions for detection and enumeration of genetic variations |
EP1524321B2 (en) | 2003-10-16 | 2014-07-23 | Sequenom, Inc. | Non-invasive detection of fetal genetic traits |
DE10348407A1 (de) | 2003-10-17 | 2005-05-19 | Widschwendter, Martin, Prof. | Prognostische und diagnostische Marker für Zell-proliferative Erkrankungen von Brustgeweben |
NZ547492A (en) * | 2003-10-28 | 2009-12-24 | Bioarray Solutions Ltd | Optimization of gene expression analysis using immobilized capture probes of different lengths and densities |
US20100216153A1 (en) | 2004-02-27 | 2010-08-26 | Helicos Biosciences Corporation | Methods for detecting fetal nucleic acids and diagnosing fetal abnormalities |
US7937225B2 (en) | 2004-09-03 | 2011-05-03 | New York University | Systems, methods and software arrangements for detection of genome copy number variation |
EP1647600A3 (en) | 2004-09-17 | 2006-06-28 | Affymetrix, Inc. (A US Entity) | Methods for identifying biological samples by addition of nucleic acid bar-code tags |
WO2006047787A2 (en) | 2004-10-27 | 2006-05-04 | Exact Sciences Corporation | Method for monitoring disease progression or recurrence |
US7424371B2 (en) | 2004-12-21 | 2008-09-09 | Helicos Biosciences Corporation | Nucleic acid analysis |
US7393665B2 (en) | 2005-02-10 | 2008-07-01 | Population Genetics Technologies Ltd | Methods and compositions for tagging and identifying polynucleotides |
ITRM20050068A1 (it) | 2005-02-17 | 2006-08-18 | Istituto Naz Per Le Malattie I | Metodo per la rivelazione di acidi nucleici di agenti patogeni batterici o di parassiti nelle urine. |
PL1712639T3 (pl) | 2005-04-06 | 2009-02-27 | Maurice Stroun | Sposób diagnozowania nowotworu przez wykrywanie krążącego DNA i RNA |
US7666593B2 (en) | 2005-08-26 | 2010-02-23 | Helicos Biosciences Corporation | Single molecule sequencing of captured nucleic acids |
US20090170713A1 (en) | 2005-09-29 | 2009-07-02 | Keygene N.V. | High throughput screening of mutagenized populations |
WO2007087312A2 (en) | 2006-01-23 | 2007-08-02 | Population Genetics Technologies Ltd. | Molecular counting |
US8383338B2 (en) | 2006-04-24 | 2013-02-26 | Roche Nimblegen, Inc. | Methods and systems for uniform enrichment of genomic regions |
JP2009537154A (ja) | 2006-05-18 | 2009-10-29 | モレキュラー プロファイリング インスティテュート, インコーポレイテッド | 疾患状態に対する個別化された医学的介入を決定するためのシステムおよび方法 |
WO2007147018A1 (en) | 2006-06-14 | 2007-12-21 | Cellpoint Diagnostics, Inc. | Analysis of rare cell-enriched samples |
ES2679996T3 (es) | 2006-11-15 | 2018-09-03 | Biospherex Llc | Secuenciación multi-etiqueta y análisis ecogenómico |
US20080131887A1 (en) | 2006-11-30 | 2008-06-05 | Stephan Dietrich A | Genetic Analysis Systems and Methods |
WO2008148072A2 (en) | 2007-05-24 | 2008-12-04 | The Brigham And Women's Hospital, Inc. | Disease-associated genetic variations and methods for obtaining and using same |
EP2164985A4 (en) | 2007-06-01 | 2014-05-14 | 454 Life Sciences Corp | SYSTEM AND METHOD FOR IDENTIFYING INDIVIDUAL SAMPLES FROM A MULTIPLEX MIXTURE |
CA3176319A1 (en) | 2007-07-23 | 2009-01-29 | The Chinese University Of Hong Kong | Analyzing tumor dna in a cell-free sample |
US8338838B2 (en) | 2007-12-28 | 2012-12-25 | 3M Innovative Properties Company | Down-converted light source with uniform wavelength emission |
WO2009099602A1 (en) | 2008-02-04 | 2009-08-13 | Massachusetts Institute Of Technology | Selection of nucleic acids by solution hybridization to oligonucleotide baits |
US20110171640A1 (en) | 2008-02-12 | 2011-07-14 | Novartis Vaccines And Diagnostics, Inc. | Method for isolating cell free apoptotic or fetal nucleic acids |
BRPI0909212A2 (pt) | 2008-03-28 | 2015-08-18 | Pacific Biosciences California | Composições e método para sequeciamento de ácido nucléico |
US20090318305A1 (en) | 2008-06-18 | 2009-12-24 | Xi Erick Lin | Methods for selectively capturing and amplifying exons or targeted genomic regions from biological samples |
US20100069250A1 (en) | 2008-08-16 | 2010-03-18 | The Board Of Trustees Of The Leland Stanford Junior University | Digital PCR Calibration for High Throughput Sequencing |
US8383345B2 (en) | 2008-09-12 | 2013-02-26 | University Of Washington | Sequence tag directed subassembly of short sequencing reads into long sequencing reads |
US20100323348A1 (en) | 2009-01-31 | 2010-12-23 | The Regents Of The University Of Colorado, A Body Corporate | Methods and Compositions for Using Error-Detecting and/or Error-Correcting Barcodes in Nucleic Acid Amplification Process |
US9085798B2 (en) | 2009-04-30 | 2015-07-21 | Prognosys Biosciences, Inc. | Nucleic acid constructs and methods of use |
AU2011207544A1 (en) | 2010-01-19 | 2012-09-06 | Verinata Health, Inc. | Identification of polymorphic sequences in mixtures of genomic DNA by whole genome sequencing |
EP2848703A1 (en) | 2010-01-19 | 2015-03-18 | Verinata Health, Inc | Simultaneous determination of aneuploidy and fetal fraction |
US20120046877A1 (en) | 2010-07-06 | 2012-02-23 | Life Technologies Corporation | Systems and methods to detect copy number variation |
EP2599545B1 (en) | 2010-07-29 | 2019-09-04 | Toto Ltd. | Photocatalyst coated body and photocatalyst coating liquid |
PT2623613T (pt) | 2010-09-21 | 2016-10-11 | Population Genetics Tech Ltd | Aumento da confiança da designação de alelos por contagem molecular |
US8725422B2 (en) | 2010-10-13 | 2014-05-13 | Complete Genomics, Inc. | Methods for estimating genome-wide copy number variations |
ES2688458T5 (es) | 2010-10-22 | 2022-04-13 | Cold Spring Harbor Laboratory | Recuento varietal de ácidos nucleicos para obtener información del número de copias genómicas |
KR20210131432A (ko) * | 2010-12-30 | 2021-11-02 | 파운데이션 메디신 인코포레이티드 | 종양 샘플의 다유전자 분석의 최적화 |
CN103608818B (zh) * | 2011-02-09 | 2017-12-08 | 纳特拉公司 | 非侵入性产前倍性识别装置 |
WO2012129363A2 (en) | 2011-03-24 | 2012-09-27 | President And Fellows Of Harvard College | Single cell nucleic acid detection and analysis |
PL2697397T3 (pl) | 2011-04-15 | 2017-08-31 | The Johns Hopkins University | System bezpiecznego sekwencjonowania |
JP2014512826A (ja) | 2011-04-25 | 2014-05-29 | バイオ−ラド ラボラトリーズ インコーポレイテッド | 核酸分析のための方法および組成物 |
SG194745A1 (en) | 2011-05-20 | 2013-12-30 | Fluidigm Corp | Nucleic acid encoding reactions |
KR101454886B1 (ko) | 2011-08-01 | 2014-11-03 | 주식회사 셀레믹스 | 핵산분자의 제조방법 |
ES2729554T3 (es) | 2011-10-21 | 2019-11-04 | Chronix Biomedical | Biomarcadores de ácidos nucleicos en circulación asociados al cáncer colorrectal |
EP2771483A1 (en) | 2011-10-25 | 2014-09-03 | ONCOTYROL - Center for Personalized Cancer Medicine GmbH | Method for diagnosing a disease based on plasma-dna distribution |
US10011871B2 (en) | 2012-02-17 | 2018-07-03 | Fred Hutchinson Cancer Research Center | Compositions and methods for accurately identifying mutations |
US11261494B2 (en) * | 2012-06-21 | 2022-03-01 | The Chinese University Of Hong Kong | Method of measuring a fractional concentration of tumor DNA |
US20140066317A1 (en) | 2012-09-04 | 2014-03-06 | Guardant Health, Inc. | Systems and methods to detect rare mutations and copy number variation |
IL305303A (en) | 2012-09-04 | 2023-10-01 | Guardant Health Inc | Systems and methods for detecting rare mutations and changes in number of copies |
US20160040229A1 (en) * | 2013-08-16 | 2016-02-11 | Guardant Health, Inc. | Systems and methods to detect rare mutations and copy number variation |
US20140287408A1 (en) * | 2013-03-13 | 2014-09-25 | Abbott Molecular Inc. | Target sequence enrichment |
GB2528205B (en) | 2013-03-15 | 2020-06-03 | Guardant Health Inc | Systems and methods to detect rare mutations and copy number variation |
CN105518151B (zh) | 2013-03-15 | 2021-05-25 | 莱兰斯坦福初级大学评议会 | 循环核酸肿瘤标志物的鉴别和用途 |
CN111394426B (zh) | 2013-05-23 | 2024-05-10 | 斯坦福大学托管董事会 | 用于个人表观基因组学的至天然染色质的转座 |
JP6571665B2 (ja) | 2013-12-28 | 2019-09-04 | ガーダント ヘルス, インコーポレイテッド | 遺伝的バリアントを検出するための方法およびシステム |
CN106460070B (zh) | 2014-04-21 | 2021-10-08 | 纳特拉公司 | 检测染色体片段中的突变和倍性 |
ES2844229T3 (es) | 2014-05-13 | 2021-07-21 | Univ Texas | Mutaciones génicas y alteraciones en el número de copias de EGFR, KRAS y MET |
PL3178941T3 (pl) | 2014-07-25 | 2022-02-14 | Bgi Genomics Co., Limited | Sposób oznaczania frakcji wolnych pozakomórkowych płodowych kwasów nukleinowych w próbce krwi obwodowej kobiety ciężarnej i jego zastosowanie |
AU2015292311B2 (en) | 2014-07-25 | 2022-01-20 | University Of Washington | Methods of determining tissues and/or cell types giving rise to cell-free DNA, and methods of identifying a disease or disorder using same |
US20160053301A1 (en) | 2014-08-22 | 2016-02-25 | Clearfork Bioscience, Inc. | Methods for quantitative genetic analysis of cell free dna |
WO2016040901A1 (en) | 2014-09-12 | 2016-03-17 | The Board Of Trustees Of The Leland Stanford Junior University | Identification and use of circulating nucleic acids |
US20160122817A1 (en) * | 2014-10-29 | 2016-05-05 | 10X Genomics, Inc. | Methods and compositions for targeted nucleic acid sequencing |
ES2923602T3 (es) | 2014-12-31 | 2022-09-28 | Guardant Health Inc | Detección y tratamiento de enfermedades que muestran heterogeneidad celular de enfermedad y sistemas y métodos para comunicar los resultados de las pruebas |
SG11201706529TA (en) | 2015-02-10 | 2017-09-28 | Univ Hong Kong Chinese | Detecting mutations for cancer screening and fetal analysis |
US20160281166A1 (en) * | 2015-03-23 | 2016-09-29 | Parabase Genomics, Inc. | Methods and systems for screening diseases in subjects |
AU2016258914A1 (en) | 2015-05-01 | 2017-11-09 | Guardant Health, Inc. | Diagnostic methods |
EP3325667B1 (en) | 2015-07-21 | 2020-11-11 | Guardant Health, Inc. | Locked nucleic acids for capturing fusion genes |
HUE064231T2 (hu) | 2015-07-23 | 2024-02-28 | Univ Hong Kong Chinese | Sejtmentes DNS fragmentációs mintázatának elemzése |
US11302416B2 (en) | 2015-09-02 | 2022-04-12 | Guardant Health | Machine learning for somatic single nucleotide variant detection in cell-free tumor nucleic acid sequencing applications |
US20170058332A1 (en) | 2015-09-02 | 2017-03-02 | Guardant Health, Inc. | Identification of somatic mutations versus germline variants for cell-free dna variant calling applications |
JP6991134B2 (ja) | 2015-10-09 | 2022-01-12 | ガーダント ヘルス, インコーポレイテッド | 無細胞dnaを使用する集団ベースの処置レコメンダ |
EP3359695B1 (en) | 2015-10-10 | 2020-04-15 | Guardant Health, Inc. | Methods and applications of gene fusion detection in cell-free dna analysis |
CN108603228B (zh) | 2015-12-17 | 2023-09-01 | 夸登特健康公司 | 通过分析无细胞dna确定肿瘤基因拷贝数的方法 |
CA3013366A1 (en) | 2016-02-02 | 2017-08-10 | Guardant Health, Inc. | Cancer evolution detection and diagnostic |
US9850523B1 (en) * | 2016-09-30 | 2017-12-26 | Guardant Health, Inc. | Methods for multi-resolution analysis of cell-free nucleic acids |
ES2840003T3 (es) | 2016-09-30 | 2021-07-06 | Guardant Health Inc | Métodos para análisis multi-resolución de ácidos nucleicos libres de células |
-
2017
- 2017-09-29 ES ES17857586T patent/ES2840003T3/es active Active
- 2017-09-29 KR KR1020217042039A patent/KR20210158870A/ko not_active Application Discontinuation
- 2017-09-29 WO PCT/US2017/054607 patent/WO2018064629A1/en unknown
- 2017-09-29 CA CA3027919A patent/CA3027919C/en active Active
- 2017-09-29 EP EP20203923.6A patent/EP3792922A1/en active Pending
- 2017-09-29 US US16/338,445 patent/US20200013482A1/en not_active Abandoned
- 2017-09-29 JP JP2018568202A patent/JP6560465B1/ja active Active
- 2017-09-29 SG SG11201811159SA patent/SG11201811159SA/en unknown
- 2017-09-29 CA CA3126055A patent/CA3126055A1/en active Pending
- 2017-09-29 EP EP17857586.6A patent/EP3461274B1/en active Active
- 2017-09-29 KR KR1020187038033A patent/KR102344635B1/ko active IP Right Grant
- 2017-09-29 AU AU2017336153A patent/AU2017336153B2/en active Active
- 2017-09-29 CN CN201780049135.9A patent/CN109642250A/zh active Pending
-
2019
- 2019-07-18 JP JP2019132431A patent/JP6806854B2/ja active Active
- 2019-12-18 US US16/719,768 patent/US11062791B2/en active Active
-
2020
- 2020-12-04 JP JP2020201573A patent/JP7022188B2/ja active Active
-
2021
- 2021-07-22 US US17/383,385 patent/US20210358567A1/en active Pending
-
2022
- 2022-02-04 JP JP2022016332A patent/JP7385686B2/ja active Active
- 2022-11-14 US US18/055,298 patent/US11817177B2/en active Active
-
2023
- 2023-01-17 US US18/155,523 patent/US11817179B2/en active Active
- 2023-06-27 AU AU2023204088A patent/AU2023204088A1/en active Pending
- 2023-11-07 US US18/503,392 patent/US20240087680A1/en active Pending
- 2023-11-10 US US18/506,734 patent/US20240087681A1/en active Pending
- 2023-11-10 JP JP2023192159A patent/JP2024012567A/ja active Pending
Also Published As
Similar Documents
Publication | Publication Date | Title |
---|---|---|
SG11201811159SA (en) | Methods for multi-resolution analysis of cell-free nucleic acids | |
SG11201805119QA (en) | Methods to determine tumor gene copy number by analysis of cell-free dna | |
SG11201908658TA (en) | Nucleobase editors comprising nucleic acid programmable dna binding proteins | |
SG11201906161VA (en) | Microorganisms programmed to produce immune modulators and anti-cancer therapeutics in tumor cells | |
SG11201907618RA (en) | Automated storage and retrieval systems and methods | |
SG11201903697WA (en) | Liver organoid compositions and methods of making and using same | |
SG11201903882VA (en) | Il-2 variants for the treatment of autoimmune diseases | |
SG11201805217XA (en) | Compositions and methods for the treatment of hemoglobinopathies | |
SG11201804836RA (en) | Treatment of fibrosis | |
SG11201908489XA (en) | De novo synthesized combinatorial nucleic acid libraries | |
SG11201807487WA (en) | Generation of midbrain-specific organoids from human pluripotent stem cells | |
SG11201809963XA (en) | Application framework using blockchain-based asset ownership | |
SG11201901334SA (en) | Convolutional neural network-based mode selection and defect classification for image fusion | |
SG11201806002SA (en) | Methods for extending the replicative capacity of somatic cells during an ex vivo cultivation process | |
SG11201807077RA (en) | Solid forms of a thienopyrimidinedione acc inhibitor and methods for production thereof | |
SG11201806630QA (en) | Self-propelled personal transportation device | |
SG11201811025VA (en) | Systems and methods for automated annotation and screening of biological sequences | |
SG11201804814YA (en) | Materials and methods for delivering nucleic acids to cochlear and vestibular cells | |
SG11201808721YA (en) | Cell-free production of ribonucleic acid | |
SG11201805577XA (en) | Techniques for manipulation of two-qubit quantum states and related systems and methods | |
SG11201407486PA (en) | Compositions and methods for modulating utrn expression | |
SG11201806609TA (en) | Cancer evolution detection and diagnostic | |
SG11201811232XA (en) | Treatment of amd using aav2 variant with aflibercept | |
SG11201407483YA (en) | Compositions and methods for modulating smn gene family expression | |
SG11201805680SA (en) | Methods and compositions for the treatment of neurologic disease |